+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis

The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis

Journal of Neurology 251(8): 1006-1011

Myasthenia gravis (MG) is caused by autoantibodies to acetylcholine receptors (AChR). Non-AChR muscle autoantibodies, such as titin antibodies, are present in sera of many MG patients. To study the correlation between titin antibodies and the features of MG, the cDNA segment encoding MGT-30 was amplified and sequenced. The cloned MGT-30 cDNA was expressed in vector pET-30a, and then transfected into E.coli. BL21. We examined titin antibodies in sera of 265 normal subjects, 154 MG patients with different thymic pathology and 48 patients with other neurological diseases. Titin antibodies occurred more frequently in MGT, especially in MG with epithelial predominant-thymoma, and were correlated with the severity of disease. The levels of titin antibodies were reduced 6 months after thymectomy. The specificity of titin antibodies for the detection of thymoma was higher than that of CT examination in MG with thymoma. These results suggest that titin antibodies could be useful in both diagnosis and follow-up of MG patients with thymoma.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 050733074

Download citation: RISBibTeXText

PMID: 15316806

DOI: 10.1007/s00415-004-0479-z

Related references

Correlation between myasthenia gravis-activities of daily living (MG-ADL) and quantitative myasthenia gravis (QMG) assessments of anti-acetylcholine receptor antibody-positive refractory generalized myasthenia gravis in the phase 3 regain study. Muscle and Nerve 58(2): E21-E22, 2018

The significance of Titin antibody in diagnosing myasthenia gravis with thymoma. Zhonghua Yi Xue Za Zhi 81(18): 1118-1120, 2001

Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis. Clinica Chimica Acta; International Journal of Clinical Chemistry 201(3): 201-205, 1991

Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma. Annals of the new York Academy of Sciences 841: 538-541, 1998

Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. Archives of Neurology 58(6): 885-890, 2001

Post-thymomectomy myasthenia gravis. Report of a case of ocular myasthenia gravis after total removal of a thymoma and review of literature. Neurology 17(4): 413-420, 1967

Pemphigus foliaceus, myasthenia gravis, thymoma and red cell aplasia. A case report and indirect immunofluorescence study on 38 patients with myasthenia gravis. Clinical and Experimental Dermatology 3(3): 285-291, 1978

Myasthenia gravis with thymoma: analysis of and postoperative prognosis for 65 patients with thymomatous myasthenia gravis. Annals of Thoracic Surgery 38(1): 46-52, 1984

A case of late-onset, thymoma-associated myasthenia gravis with ryanodine receptor and titin antibodies and concomitant granulomatous myositis. Bmc Neurology 16(1): 172, 2016

Titin, thymoma, and myasthenia gravis. Archives of Neurology 58(6): 869-870, 2001

The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. Archives of Neurology 57(11): 1596-1600, 2000

Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis. Journal of Neurology, Neurosurgery, and Psychiatry 57(7): 843-846, 1994

Myasthenia gravis (1). Experimental myasthenia gravis--a tool for the study of the pathogenesis, diagnosis and treatment of myasthenia gravis. Lakartidningen 75(41): 3663-4 3669, 1978

Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clinical and Experimental Immunology 82(2): 284-288, 1990

The correlation between the myasthenia gravis activity of daily living profile and the quantitative myasthenia gravis score. Neurology 50(4 Suppl. 4): A22, 1998